Also trades as: IBO.V (TSXV) · $vol 0M
IBOGF OTC
Universal Ibogaine Inc.
1W: -99.0%
1M: -99.5%
3M: -99.6%
YTD: -98.0%
1Y: -98.8%
3Y: -99.1%
$0.00
-0.00 (-50.00%)
Weekly Expected Move ±623575.0%
$-1
$-1
$0
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+0.0% ▲
Gross Profit
$1M
+0.0% ▲
Operating Income
$497K
+113.0% ▲
4Y CAGR: +67.0%
Net Income
-$10M
-171.4% ▼
EPS (Diluted)
$-0.06
-82.8% ▼
EBITDA
-$5M
-22.4% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $1M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $1M |
| Gross Margin | — | — | — | — | 100.0% |
| R&D Expenses | $0 | $0 | $0 | $63K | $409K |
| SG&A Expenses | $176K | $69K | $59K | $4M | $5M |
| Operating Expenses | $176K | $69K | $59K | $4M | $6M |
| Operating Income | $64K | -$34K | $383 | -$4M | $497K |
| Operating Margin | — | — | — | — | 46.4% |
| Interest Expense | $0 | $0 | $0 | $15K | $68K |
| Income Before Tax | -$408K | -$98K | -$118K | -$4M | -$10M |
| Tax Expense | $0 | $0 | $59K | $15K | -$60K |
| Net Income | -$408K | -$98K | -$118K | -$4M | -$10M |
| Net Margin | — | — | — | — | -980.2% |
| EPS (Diluted) | $-0.04 | $-0.01 | $-0.01 | $-0.03 | $-0.06 |
| EBITDA | $64K | -$34K | $638 | -$4M | -$5M |
| Shares Outstanding | 10M | 10M | 12M | 125M | 186M |